Literature DB >> 21037042

The obesity paradox and mortality associated with surrogates of body size and muscle mass in patients receiving hemodialysis.

Kamyar Kalantar-Zadeh1, Elani Streja, Csaba P Kovesdy, Antigone Oreopoulos, Nazanin Noori, Jennie Jing, Allen R Nissenson, Mahesh Krishnan, Joel D Kopple, Rajnish Mehrotra, Stefan D Anker.   

Abstract

OBJECTIVE: To determine whether dry weight gain accompanied by an increase in muscle mass is associated with a survival benefit in patients receiving maintenance hemodialysis (HD). PATIENTS AND METHODS: In a nationally representative 5-year cohort of 121,762 patients receiving HD 3 times weekly from July 1, 2001, through June 30, 2006, we examined whether body mass index (BMI) (calculated using 3-month averaged post-HD dry weight) and 3-month averaged serum creatinine levels (a likely surrogate of muscle mass) and their changes over time were predictive of mortality risk.
RESULTS: In the cohort, higher BMI (up to 45) and higher serum creatinine concentration were incrementally and independently associated with greater survival, even after extensive multivariate adjustment for available surrogates of nutritional status and inflammation. Dry weight loss or gain over time exhibited a graded association with higher rates of mortality or survival, respectively, as did changes in serum creatinine level over time. Among the 50,831 patients who survived the first 6 months and who had available data for changes in weight and creatinine level, those who lost weight but had an increased serum creatinine level had a greater survival rate than those who gained weight but had a decreased creatinine level. These associations appeared consistent across different demographic groups of patients receiving HD.
CONCLUSION: In patients receiving long-term HD, larger body size with more muscle mass appears associated with a higher survival rate. A discordant muscle gain with weight loss over time may confer more survival benefit than weight gain while losing muscle. Controlled trials of muscle-gaining interventions in patients receiving HD are warranted.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21037042      PMCID: PMC2966362          DOI: 10.4065/mcp.2010.0336

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  62 in total

1.  Blood pressure and survival in long-term hemodialysis patients with and without polycystic kidney disease.

Authors:  Miklos Z Molnar; Lilia R Lukowsky; Elani Streja; Ramanath Dukkipati; Jennie Jing; Allen R Nissenson; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  J Hypertens       Date:  2010-12       Impact factor: 4.844

2.  Postprandial serum creatinine increase in normal subjects after eating cooked meat.

Authors:  F K Jacobsen; C K Christensen; C E Mogensen; F Andreasen; N S Heilskov
Journal:  Proc Eur Dial Transplant Assoc       Date:  1979

3.  Lean body mass estimation by creatinine kinetics.

Authors:  P R Keshaviah; K D Nolph; H L Moore; B Prowant; P F Emerson; M Meyer; Z J Twardowski; R Khanna; L Ponferrada; A Collins
Journal:  J Am Soc Nephrol       Date:  1994-01       Impact factor: 10.121

Review 4.  Body weight and mortality.

Authors:  R F Kushner
Journal:  Nutr Rev       Date:  1993-05       Impact factor: 7.110

Review 5.  Creatinine excretion as a measure of protein nutrition in adults of varying age.

Authors:  M Walser
Journal:  JPEN J Parenter Enteral Nutr       Date:  1987 Sep-Oct       Impact factor: 4.016

6.  Dietary intake and counseling, weight maintenance, and the course of HIV infection.

Authors:  R T Chlebowski; M Grosvenor; L Lillington; J Sayre; G Beall
Journal:  J Am Diet Assoc       Date:  1995-04

7.  Enhanced muscle protein degradation and amino acid release from the hemicorpus of acutely uremic rats.

Authors:  R M Flugel-Link; I B Salusky; M R Jones; J D Kopple
Journal:  Adv Exp Med Biol       Date:  1984       Impact factor: 2.622

Review 8.  Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure.

Authors:  Kamyar Kalantar-Zadeh; Gladys Block; Tamara Horwich; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2004-04-21       Impact factor: 24.094

9.  Total plasma creatinine: an accurate measure of total striated muscle mass.

Authors:  J E Schutte; J C Longhurst; F A Gaffney; B C Bastian; C G Blomqvist
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1981-09

10.  Mortality risk factors in patients treated by chronic hemodialysis. Report of the Diaphane collaborative study.

Authors:  P Degoulet; M Legrain; I Réach; F Aimé; C Devriés; P Rojas; C Jacobs
Journal:  Nephron       Date:  1982       Impact factor: 2.847

View more
  128 in total

1.  Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States.

Authors:  Deep Sharma; Meredith Hawkins; Matthew K Abramowitz
Journal:  Clin J Am Soc Nephrol       Date:  2014-11-12       Impact factor: 8.237

2.  Association of pretransplant serum phosphorus with posttransplant outcomes.

Authors:  Marcelo S Sampaio; Miklos Z Molnar; Csaba P Kovesdy; Rajnish Mehrotra; Istvan Mucsi; John J Sim; Mahesh Krishnan; Allen R Nissenson; Kamyar Kalantar-Zadeh
Journal:  Clin J Am Soc Nephrol       Date:  2011-09-29       Impact factor: 8.237

3.  Association between BMI changes and mortality risk in children with end-stage renal disease.

Authors:  Matthew J Roberts; Mark M Mitsnefes; Charles E McCulloch; Larry A Greenbaum; Barbara A Grimes; Elaine Ku
Journal:  Pediatr Nephrol       Date:  2019-04-08       Impact factor: 3.714

4.  Predictive Score for Posttransplantation Outcomes.

Authors:  Miklos Z Molnar; Danh V Nguyen; Yanjun Chen; Vanessa Ravel; Elani Streja; Mahesh Krishnan; Csaba P Kovesdy; Rajnish Mehrotra; Kamyar Kalantar-Zadeh
Journal:  Transplantation       Date:  2017-06       Impact factor: 4.939

5.  Novel equations to estimate lean body mass in maintenance hemodialysis patients.

Authors:  Nazanin Noori; Csaba P Kovesdy; Rachelle Bross; Martin Lee; Antigone Oreopoulos; Deborah Benner; Rajnish Mehrotra; Joel D Kopple; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2011-01       Impact factor: 8.860

6.  To legitimize the contentious obesity paradox.

Authors:  Kamyar Kalantar-Zadeh; Connie M Rhee; Alpesh N Amin
Journal:  Mayo Clin Proc       Date:  2014-08       Impact factor: 7.616

7.  Silent diabetic nephropathy.

Authors:  Katia López-Revuelta; Patricia Peña Galdo; Ramona Stanescu; Leticia Parejo; Carmen Guerrero; Elia Pérez-Fernández
Journal:  World J Nephrol       Date:  2014-02-06

Review 8.  Obesity paradox in end-stage kidney disease patients.

Authors:  Jongha Park; Seyed-Foad Ahmadi; Elani Streja; Miklos Z Molnar; Katherine M Flegal; Daniel Gillen; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Prog Cardiovasc Dis       Date:  2013-10-09       Impact factor: 8.194

9.  Concurrence of Serum Creatinine and Albumin With Lower Risk for Death in Twice-Weekly Hemodialysis Patients.

Authors:  Jialin Wang; Elani Streja; Melissa Soohoo; Joline L T Chen; Connie M Rhee; Taehee Kim; Miklos Z Molnar; Csaba P Kovesdy; Rajnish Mehrotra; Kamyar Kalantar-Zadeh
Journal:  J Ren Nutr       Date:  2016-08-12       Impact factor: 3.655

10.  Chronic Kidney Disease and the Adiposity Paradox: Valid or Confounded?

Authors:  Susan L Ziolkowski; Jin Long; Joshua F Baker; Glenn M Chertow; Mary B Leonard
Journal:  J Ren Nutr       Date:  2019-01-29       Impact factor: 3.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.